A search for "US patent acarbose gene cluster" does not yield specific results directly linking US patents to a "gene cluster" for acarbose. Acarbose is an oral medication used to treat type 2 diabetes. It functions as an alpha-glucosidase inhibitor, slowing down the digestion of carbohydrates [1].
What is Acarbose Used For?
Acarbose is prescribed to help control blood sugar levels in individuals with type 2 diabetes [1]. By inhibiting the enzymes that break down complex carbohydrates in the small intestine, it reduces the post-meal spike in blood glucose [2].
How Does Acarbose Work?
Acarbose works by competitively inhibiting alpha-glucosidases in the brush border of the small intestine. These enzymes are responsible for breaking down disaccharides, trisaccharides, and oligosaccharides into monosaccharides, which are then absorbed into the bloodstream. By slowing this process, acarbose delays glucose absorption and lowers postprandial hyperglycemia [1][2].
When Does Acarbose Patent Expiration Occur?
Information regarding the specific patent expiration dates for acarbose in the US is not readily available through this query. Drug patent information can be complex, involving multiple patents covering different aspects of a drug, such as formulation, manufacturing processes, and new uses. For detailed patent status and expiration timelines, resources like DrugPatentWatch.com can be consulted [3].
Are There Generic Versions of Acarbose Available?
Yes, generic versions of acarbose are available [4]. The availability of generics typically follows the expiration of primary patents protecting the original branded drug.
What Are the Side Effects of Acarbose?
Common side effects of acarbose include gastrointestinal issues such as diarrhea, abdominal pain, bloating, and gas [1]. These side effects are often related to the mechanism of action, where undigested carbohydrates reach the colon and are fermented by bacteria [2].
What is the Mechanism of Action for Acarbose?
Acarbose's mechanism of action involves the inhibition of alpha-glucosidases, primarily sucrase and maltase, in the intestinal brush border. This delays the hydrolysis of dietary carbohydrates into absorbable monosaccharides, thereby reducing postprandial glucose levels [1][2].
What are the Alternatives to Acarbose for Type 2 Diabetes?
Several other classes of medications are used to manage type 2 diabetes, including metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, and insulin [5]. The choice of treatment depends on individual patient factors, disease severity, and other medical conditions [5].
Sources:
[1] https://www.mayoclinic.org/drugs-supplements/acarbose-oral-route/proper-use/drg-20061128
[2] https://www.ncbi.nlm.nih.gov/books/NBK557468/
[3] https://drugpatentwatch.com/
[4] https://www.goodrx.com/acarbose
[5] https://www.niddk.nih.gov/health-information/diabetes/overview-diabetes/type-2-diabetes/treatment